Search

everythinglearnresearchcommunity

for

Search:↓

Adolescents with severe alopecia incur significantly higher healthcare costs.

Treating chronic hand eczema costs about the same in statutory and occupational health insurances in Germany, but work-related cases may lead to higher indirect costs due to longer work absences.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

Some people pay $240 for medication that costs $9 due to drug industry tactics and complicated healthcare policies.

Middle-aged patients, those in the Northeast, with comprehensive insurance, extensive hair loss, or additional health issues, and young or older females face higher alopecia areata medical costs.

CPDC offers significant cost savings on men's health medications compared to Medicare and GoodRx.

Alopecia areata in Romania has a high economic burden, with significant costs and unequal healthcare access.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Alopecia areata causes significant emotional distress, requiring treatments that focus on mental health and social support, not just hair regrowth.

Reducing out-of-pocket costs increased colorectal cancer screenings.

Psoriasis increases annual healthcare costs by $4,044 per patient, with biologic treatments costing significantly more than phototherapy.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Targeted testing for telogen effluvium patients can save healthcare costs.

Alopecia areata in Dubai mostly affects men, often involves autoimmune disorders, and has high healthcare costs, especially for psychological issues.

Choose cost-effective emollients for dry skin conditions and prescribe appropriate amounts.

Alopecia areata and atopic dermatitis have similar healthcare costs, but alopecia areata leads to more outpatient and long-term disability expenses.

Adopting the Mark Cuban Cost Plus Drug Company pricing model could save Medicare about $1.29 billion on urological drugs.

Alopecia areata significantly strains healthcare and finances in the UAE, needing better management.

Healthcare organizations must seriously focus on strategic decision-making to succeed in a complex market.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Racial minorities face higher costs for unplanned hospital visits after breast reconstruction.

Hair health is influenced by genetics, lifestyle, and modern treatments, but practical solutions are limited.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

The document concludes that there is no clear definition of adequate health insurance, and a consistent method to measure underinsurance is needed.

Women's minoxidil products cost more and are less effective than men's.

Finasteride may increase depression and suicide risks, needing better safety checks and informed consent.

BPH management needs better long-term studies and prevention strategies.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.